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MafB, a transcription factor expressed selectively in macrophages, has
important roles in some macrophage-related diseases, especially in
atherosclerosis. In this study, we investigated the mechanism by which
hematopoietic-specific MafB deficiency induces the development of obesity.
Wild-type and hematopoietic cell-specific Mafb-deficient mice were fed a
high-fat diet for 10 weeks. The Mafb-deficient mice exhibited higher body
weights and faster rates of body weight increase than control mice. The
Mafb-deficient mice also had a higher percentage of body fat than the
wild-type mice, due to increased adipocyte size and serum cholesterol
levels. Reverse transcription-PCR analysis showed a reduction in apoptosis
inhibitor of macrophage (AIM) in Mafb-deficient adipose tissue. AIM is
known as an inhibitor of lipogenesis in adipocytes and is expressed in
adipose tissue macrophages. Collectively, our data suggest that Mafb
deficiency in hematopoietic cells accelerates the development of obesity.
MafB, also known as v-maf musculoaponeurotic
fibrosarcoma oncogene homolog B, belongs to the
large Maf transcription factor family, the members of
which contain basic leucine zipper (bZIP) domains
that bind to DNA. These bZIP domains are located
within the Maf recognition element (MARE) and regu-
late the transcription of target genes by binding to
acidic domains within the genes [1]. MafB plays vari-
ous roles in a variety of differentiation processes,
including the differentiation of pancreatic a and b
cells, podocytes in the renal glomerulus, and rhom-
bomeres (r5) in the embryonic hindbrain. MafB is also
central to embryonic thymus development, parathyroid
gland development, the creation of hair cuticles, and
urethral masculinization [2–7]. In the hematopoietic
system, MafB is important for myeloid lineage com-
mitment of hematopoietic stem cells and for macro-
phage differentiation [5,8]. Recently, we reported that
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MafB expression is induced by liver X receptor
(LXR), which is activated by oxidized low-density
lipoprotein (LDL) and regulates apoptosis inhibitor of
macrophage (AIM, also called Api6/Spa/CD5L). Con-
sistently, MafB deficiency has been shown to amelio-
rate atherosclerotic lesions due to increased apoptosis
of foam cells [9].
Apoptosis inhibitor of macrophage, a member of
the scavenger receptor cysteine-rich superfamily, is a
soluble protein mainly expressed in macrophages.
AIM has multiple functions, including inhibiting the
induction of apoptosis, inducing the coagulation of
certain types of bacteria, and preventing the develop-
ment of autoimmunity by binding to IgM [10–14].
AIM expression in adipose tissue macrophages
(ATMs) plays a role in adipocyte lipolysis. AIM is
incorporated into adipocytes via CD36 scavenger
receptor-mediated endocytosis. Following this, AIM
binds to fatty acid synthase (FASN), thereby inhibiting
its activity [15,16]. AIM-deficient mice develop obesity
and increase adipose tissue mass [16]. Although MafB
regulates AIM in foam cells within atherosclerotic
lesions, it is unknown whether MafB also regulates
AIM in ATMs.
In this study, we investigated the relationship between
MafB and obesity using the following two approaches:
(1) we reconstituted hematopoietic systems in mice via
transplantation of Mafb/ fetal liver cells and fed these
mice a high-fat diet (HFD), and (2) we fed a HFD to
hematopoietic cell-specific Mafb-deficient mice (Mafbf/f::
Tie-2-Cre). Mafb-deficient mice exhibited increases in
body weight and adipose tissue weight. Quantitative
RT-PCR results showed that AIM expression
decreased in Mafb-deficient adipose tissue. Our results
indicate that MafB inhibits increases in fat mass under
HFD conditions.
Materials and methods
Mice
Mafb/mice were generated in a 129/Sv background and
backcrossed to the C57BL/6J strain for over seven genera-
tions [5]. The primer sequences used for genotyping were
described in previous studies [5]. For hematopoietic system
reconstitution, fetal liver cells were isolated from either
E14.5 wild-type or Mafb/ (C57BL/6J-Ly5.1) embryos.
Following this, lethally irradiated (7 Gy) 6-week-old wild-
type (C57BL/6J-Ly5.2) mice were injected with 5 9 106 fetal
liver cells per mouse via the tail vein. Donor cell chimerism
was determined based on the Ly5.1+/(Ly5.1+ + Ly5.2+) cell
ratio. Mice with > 95% chimerism were used in further
experiments. To create Mafb conditional knock-out (KO)
mice, the Mafb gene was flanked with a loxP element with a
neomycin-resistant gene using homologous recombination in
ES cells (Mafbf/f). Following this, the mice were crossed with
Tie2-Cre knock-in mice (Mafbf/f::Tie2-Cre mice). To induce
obesity, the mice were fed a HFD for 10 weeks. Each week,
the body weight of mice and their food consumption were
measured. The mice were maintained under specific patho-
gen-free conditions in a laboratory animal resource center at
the University of Tsukuba. All experiments were performed
according to the Guide for the Care and Use of Laboratory
Animals of University of Tsukuba.
Computed tomography scanning
To evaluate the body fat percentage in mice, we performed
computed tomography (CT) scanning. Mice were anes-
thetized via intraperitoneal injection of a mixture of
medetomidine (0.3 mgkg1; Zenoaq, Fukushima, Japan),
midazolam (4 mgkg1; Astellas, Tokyo, Japan), and butor-
phanol (5 mgkg1; Meiji Seika Pharma, Tokyo, Japan).
Following this, their body fat percentage was measured
using an Aloka LCT-100A CT Scanner.
Serum cholesterol measurement
To collect serum, whole blood was collected and stored at
room temperature for 30 min. Following this, the blood was
centrifuged for 30 min at 2000 g at 4 °C, and the separated
serum was transferred into new tubes. Cholesterol levels were
measured using an Automated Clinical Chemistry Analyzer
(DRI-CHEM 7000V; Fujifilm, Tokyo, Japan).
Histological analysis
In this study, we utilized male mice for the hematopoietic
system reconstitution and female mice for conditional KO.
Epidermal fat pads were collected from wild-type and
Mafb/ mice, and inguinal and ovary fat pads were col-
lected fromMafbf/f andMafbf/f::Tie2-Cre mice. The collected
fat pads were either fixed in 4% paraformaldehyde solution
and embedded in optimum cutting temperature compound
or fixed in neutral-buffered formalin and embedded in paraf-
fin. Paraffin sections were stained with hematoxylin and
eosin (HE), and adipocyte size was measured using IMAGEJ
analysis software (NIH, Bethesda, MD, USA). The frozen
sections were incubated with rabbit anti-GFP (MBL,
Woburn, MA, USA), rabbit anti-(mouse MafB) (Bethyl,
Montgomery, TX, USA) and rat anti-(mouse Mac-2)
(Cedarlane, Burlington, NC, USA). Alexa Fluor 488-conju-
gated goat anti-(rabbit IgG) (Molecular Probes, Eugene,
OR, USA) and Cy3-conjugated donkey anti-(rat IgG) (Jack-
son ImmunoResearch, West Grove, PA, USA) were used as
secondary antibodies. Hoechst 33342 (Thermofisher, Rock-
ford, IL, USA) was used to stain nuclei.
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Quantitative RT-PCR analysis
Adipose tissue was collected and incubated with 0.5% colla-
genase A (Roche, Mannheim, Germany) for 1 h at 37 °C.
The digested adipose tissue was filtered through a 70-lm
strainer and centrifuged at 300 g for 4 min at 4 °C. The cell
pellet was collected and washed with phosphate-buffered sal-
ine. Total RNA was collected using an Isogen kit (Nippon
gene, 311-02501). cDNA was synthesized using a QuantiTect
Reverse Transcription Kit (Qiagen Valencia, CA, USA). The
mRNA levels of Mafb, AIM, and Mac-1 were measured
using SYBR green PCR master mix (Takara Bio, Otsu,
Japan). The mRNA levels of Mafb and AIM were normal-
ized to the Mac-1 mRNA level. The following primer
sequences were used: Mafb forward, 50-TGAATTTGCTG
GCACTGCTG-30; Mafb reverse, 50-AAGCACCATGCG
GTTCATACA-30;AIM forward, 50-GTACCACGACTGTA
CCCACAAGGA-30;AIM reverse, 50-GAATGAGGGCCCA
CTGAACAA-30; Mac-1forward, 50-ATGGACGCTGATG
GCAATACC-30; Mac-1 reverse, 50- TCCCCATTCACGTC
TCCCA-30;
Statistical analysis
All data are shown as the mean  SEM. P-values were
calculated using two-tailed Student’s t-tests.
Results
MafB affects body weight in mice
Because Mafb deficiency strongly reduced the expres-
sion of AIM both in foam cell within atherogenic
lesion and in vitro macrophages [9]. A Recent report
identified that AIM-deficient mice developed obesity,
because AIM inhibited adipose tissue mass in high-fat
diet (HFD) condition [16]. As this paper showed that
the cells that express AIM were adipose tissue macro-
phages, we hypothesized that MafB is also expressed
in adipose tissue macrophages and inhibits adipose
tissue mass through regulation of AIM expression. To
0
20
40
0 1 2 3 4 5 6 7 8 9 10
Body weight
WT Mafb–/–
* *
* *
*
W
ei
gh
t (
g)
(week)
0
10
20
1 2 3 4 5 6 7 8 9 10
Increase of body weight
WT Mafb–/–
**
W
ei
gh
t (
g)
(week)
Fo
od
 in
ta
ke
 (g
)
(week)
Food consumption
WT Mafb–/–
0
20
40
0 1 2 3 4 5 6 7 8 9 10
Body weight
Mafbf/f Mafbf/f ::Tie2–Cre Mafbf/f Mafbf/f ::Tie2–Cre Mafbf/f Mafbf/f ::Tie2–Cre
Mafbf/f Mafbf/f ::Tie2–Cre Mafbf/f Mafbf/f ::Tie2–Cre Mafbf/f Mafbf/f ::Tie2–Cre
W
ei
gh
t (
g)
(week)
*
*
** **
0
10
20
1 2 3 4 5 6 7 8 9 10
Increase of body weight
W
ei
gh
t (
g)
(week)
** *
0
10
20
1 2 3 4 5 6 7 8 9 10
Food consumption
(week)
0
10
20
30
0 1 2 3 4 5 6 7 8 9 10
Body weight
W
ei
gh
t (
g)
(week)
****
0
5
10
1 2 3 4 5 6 7 8 9 10
Increase of body weight
W
ei
gh
t (
g)
(week)
0
10
20
1 2 3 4 5 6 7 8 9 10
Food consumption
(week)
A
D
G
B C
E
H
F
I
Fo
od
 in
ta
ke
 (g
)
Fo
od
 in
ta
ke
 (g
)
0
10
20
1 2 3 4 5 6 7 8 9
Fig. 1. MafB deficiency accelerates the development of obesity. (A–C) Wild-type (WT) and Mafb/ mice fed with a high-fat diet (HFD). (D–
F) Mafbf/f and Mafbf/f::Tie2-Cre mice fed a HFD. (G–H) Mafbf/f and Mafbf/f::Tie2-Cre mice fed a normal diet. (A, D, and G) Body weight. (B,
E, and H) Rate of body weight increase. (C, F, and I) Food consumption. All data represent the means  SEM. *P < 0.05 (Student’s t-test).
WT, n = 6; Mafb/, n = 11; Mafbf/f, n = 8; Mafbf/f::Tie2-Cre, n = 8.
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address this hypothesis, first we examined the effects
of MafB on mouse body weight in HFD condition.
Because Mafb-deficient mice die after birth [5], we
transplanted fetal liver cells from wild-type and
Mafb/ E14.5 embryos into X-ray-irradiated recipient
mice to generate wild-type and Mafb/ hematopoietic
system-reconstituted mice. Following this, the mice
were fed a HFD for 10 weeks, and their body weights
were measured. After 9 weeks, the Mafb/ mice had
significantly higher body weights compared to the
wild-type mice (Fig. 1A). The body weights of the
Mafb/ mice also increased at a higher rate than
those of the wild-type mice (Fig. 1B). In addition, we
also generated Mafb conditional KO mice, Mafbf/f::
Tie2-Cre mice, that Mafb expression was specifically
lacked in hematopoietic stem cells and macrophages
[17–19]. After feeding these mice a HFD for 6 weeks,
their body weights and rates of body weight increase
were both higher than those of the Mafbf/f mice
(Fig. 1D,E). Food consumption did not differ between
the groups (Fig. 1C,F). Moreover, when fed a normal
diet, we found that the body weights of the Mafbf/f::
Tie2-Cre mice only slightly increased while the differ-
ence in body weight gain between the Mafbf/f::Tie2-
Cre mice and wild-type mice was not detected, and the
food consumption of both groups was similar
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Fig. 2. MafB deficiency increases fat storage in mice fed a high-fat diet (HFD). (A) Computed tomography (CT) images of wild-type (WT)
and Mafb/ mice. (B) CT images of Mafbf/f and Mafbf/f::Tie2-Cre mice. (A, B) Upper panel, Radiograph of the axial sleleton of mice; Lower
panel, Representative CT transxial images (yellow parts: fat); The red lines, position of the representative CT transxial images. (C) Body fat
percentages in WT and Mafb/ mice. (D) Body fat percentages in Mafbf/f and Mafbf/f::Tie2-Cre mice. (E) Epididymal fat pad weights in WT
and Mafb/ mice. (F) Inguinal fat pad weights in Mafbf/f and Mafbf/f::Tie2-Cre mice. (G) Ovary fat pad weights in Mafbf/f and Mafbf/f::Tie2-
Cre mice. All data are shown as the means  SEM. *P < 0.05 (Student’s t-test). WT, n = 6; Mafb/, n = 11; Mafbf/f, n = 4; Mafbf/f::Tie2-
Cre, n = 4.
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(Fig. 1G–I). Taken together, these data suggest that
MafB deficiency accelerates weight gain in mice.
MafB affects fat storage in mice
Next, we used CT scanning to measure fat storage
(Fig. 2A,B, upper panels). The CT transaxial images
showed that the Mafb/ and Mafbf/f::Tie2-Cre mice
both had higher body fat accumulations (yellow parts)
than the control mice (Fig. 2A,B, lower panels). Fur-
thermore, the whole body fat percentages of the
Mafb/ and Mafbf/f::Tie2-Cre mice were also higher
than those of control mice (Fig. 2C,D). In addition,
we collected epididymal fat pads from the wild-type
and Mafb/ mice and inguinal and ovary fat pads
from the Mafbf/f and Mafbf/f::Tie2-Cre mice and mea-
sured the fat pad weights. The data showed that the
epididymal fad pads from the Mafb/ mice tended to
have higher weights than those of the wild-type mice
(Fig. 2E). The Mafbf/f::Tie2-Cre mice had significantly
heavier inguinal and ovary fat pads than the Mafbf/f
mice (Fig. 2F,G). We also performed HE staining and
measured adipocyte sizes. The Mafb-deficient mice had
larger adipocytes than the wild-type mice (Fig. 3A,B).
The Mafbf/f::Tie2-Cre mice had larger adipocytes than
the Mafbf/f mice (Fig. 3C,D). Moreover, the Mafbf/f::
Tie2-Cre mice had higher serum cholesterol levels than
the Mafbf/f mice in both the normal diet and HFD
groups (Fig. 3E). These data indicate that MafB defi-
ciency increases the fat storage and serum cholesterol
levels in mice. Because both of the evaluated
Mafb-deficient lines (Mafbf/f::Tie2-Cre and mice recon-
stituted with Mafb/ fetal liver cells) showed a lack
of MafB in hematopoietic cells only, we hypothe-
sized that the presence of MafB in hematopoietic cells,
such as macrophages, is responsible for adipose tissue
mass.
MafB deficiency reduces AIM expression in
adipose tissue macrophages
Previous reports have shown that ATMs are associated
with development of obesity [20–22]. Because MafB
plays an important role in the development and func-
tioning of macrophages [5,9], we characterized Mafb
expression in ATMs. We collected fat pads from mice of
each genotype and made frozen sections. Then adi-
pose sections were stained with anti-MafB antibody and
L–
1
Fig. 3. MafB deficiency increases adipocyte sizes and serum cholesterol levels in mice fed a high-fat diet (HFD). (A) Hematoxylin & eosin
(HE)-stained adipose tissues from wild-type (WT) and Mafb/ mice. (B) Adipocyte sizes in WT and Mafb/ mice. (C) HE-stained adipose
tissues from Mafbf/f and Mafbf/f::Tie2-Cre mice. (D) Adipocyte sizes in Mafbf/f and Mafbf/f::Tie2-Cre mice. (E) Serum cholesterol levels in
Mafbf/f and Mafbf/f::Tie2-Cre mice fed a normal diet and a HFD. All data are shown as the means  SEM. *P < 0.05 (Student’s t-test). WT,
n = 6; Mafb/, n = 11; Mafbf/f, n = 4; Mafbf/f::Tie2-Cre, n = 4.
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anti-Mac-2 antibody, which has been previously
reported to be expressed in ATMs [23,24]. The data
showed that MafB expression was detected in Mac-2
positive Mafbf/f macrophages which indicated MafB is
expressed in adipose tissue macrophages (Fig. 4A). In
contrast, signals of MafB are not detected in Mafbf/f::
Tie2-Cre mice. Moreover, we examined immunostaining
using anti-GFP antibody and anti-Mac-2 antibody.
GFP gene was inserted into Mafb locus in Mafb-defi-
cient mice [5]. The GFP expression derived by Mafb
gene promoter was detected in Mac-2-positive macro-
phages (Fig. 4B), implying a functional role of MafB in
ATMs.
It has been previously reported that AIM-deficient
mice exhibit increased adipocyte size and body fat
weight when fed a HFD [16,25]. We have previously
demonstrated that MafB directly regulates AIM
expression in foam cells in atherosclerosis [9]. There-
fore, we investigated AIM expression in Mafb/
macrophages. We found that both Mafb and AIM
expression were significantly decreased in Mafbf/f::
Tie2-Cre mice relative to Mafbf/f mice (Fig. 4C). These
results indicate that reducing the expression of AIM in
Mafb-deficient ATMs might affect adipose tissue mass
and induce obesity.
Discussion
In this study, we first demonstrated that MafB defi-
ciency in the hematopoietic system accelerates weight
gain, enhances the body fat storage, and increases the
adipocyte size. In adipose tissue, the reduction in AIM
expression was observed in Mafb-deficient mice
(Fig. 4C). As the AIM promoter region contains a
MARE and MafB binds to this site in macrophage
within atherosclerosis lesion [9], it is possible that
MafB directly regulates AIM expression in ATMs.
Recent studies have shown that AIM is also important
for inhibiting obesity-related autoimmunity and steato-
sis-associated hepatocellular carcinoma tumor develop-
ment [26,27]. Further analysis is required to determine
whether MafB regulates AIM expression in these
cases.
Our previous study showed human MAFB and
AIM were coexpressed in atherosclerosis lesion of
patient [9]. In addition, a recent study showed that
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Fig. 4. MafB deficiency reduces the expression of AIM in adipose tissue macrophages. (A) Mafbf/f and Mafbf/f::Tie2-Cre adipose tissue
sections stained with antibodies against MafB and Mac-2. (B) Wild-type (WT) and Mafb/ adipose tissue sections stained with antibodies
against GFP and Mac-2. (C) Mafb and AIM mRNA expression measured by qRT-PCR. All data are shown as the means  SEM. *P < 0.05
(Student’s t-test). WT, n = 3; Mafb/, n = 3; Mafbf/f, n = 3; Mafbf/f::Tie2-Cre, n = 4.
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human MAFB is expressed in ATMs and MAFB
expression correlates negatively with lipogenesis and
lipolysis in human adipocytes [28]. These evidence sug-
gest that MAFB may regulate AIM expression in
human ATMs because AIM also inhibits fatty acid
synthase activity of adipocyte [16].
Both in human and mouse, MafB is regulated by
nuclear receptor transcription family such as liver x
receptor (LXR), retinoic acid receptor (RAR), or reti-
noid x receptor (RXR) in monocytes/macrophages
[9,29]. Especially, LXR regulates AIM through MafB
regulation in macrophage within atherosclerosis lesion
[9]. Further analysis is required to find which pathway
induces MafB expression in ATMs.
Overall, we showed that Mafb-deficient mice
revealed an obesity phenotype. These mice might be
useful as models in the investigation of new treatments
for obesity.
Acknowledgements
This work was supported by a Grant-in-Aid for Scien-
tific Research (26221004, 25860205, 23118504,
21220009, 1612131); the Genome Network Project
from the Ministry of Education, Culture, Sports,
Science and Technology (MEXT) of Japan; and grants
from the Uehara Memorial Foundation, Takeda
Science Foundation, and the World Premier Interna-
tional Research Center Initiative (WPI), MEXT,
Japan.
Author contributions
MTNT, MH, RK, HJ, and MN performed mouse
experiments. MTNT and MN performed histological
experiments. MTNT and RK performed qRT-PCR
analysis. YT performed CT scanning. KK and YL
measured adipocyte size. MTNT and KF generated
the Mafb conditional KO mice. MH, TK, and ST con-
tributed to hypothesis development, experimental
design, and data interpretation.
References
1 Kataoka K, Noda M and Nishizawa M (1994) Maf
nuclear oncoprotein recognizes sequences related to an
AP-1 site and forms heterodimers with both Fos and
Jun. Mol Cell Biol 14, 700–712.
2 Eychene A, Rocques N and Pouponnot C (2008) A new
MAFia in cancer. Nat Rev Cancer 8, 683–693.
3 Kamitani-Kawamoto A, Hamada M, Moriguchi T,
Miyai M, Saji F, Hatamura I, Nishikawa K,
Takayanagi H, Hitoshi S, Ikenaka K et al. (2011) MafB
interacts with Gcm2 and regulates parathyroid hormone
expression and parathyroid development. J Bone Miner
Res 26, 2463–2472.
4 Miyai M, Tanaka YG, Kamitani A, Hamada M,
Takahashi S and Kataoka K (2010) c-Maf and MafB
transcription factors are differentially expressed in
Huxley”s and Henle”s layers of the inner root sheath of
the hair follicle and regulate cuticle formation. J
Dermatol Sci 57, 178–182.
5 Moriguchi T, Hamada M, Morito N, Terunuma T,
Hasegawa K, Zhang C, Yokomizo T, Esaki R, Kuroda
E, Yoh K et al. (2006) MafB is essential for renal
development and F4/80 expression in macrophages. Mol
Cell Biol 26, 5715–5727.
6 Sultana DA, Tomita S, Hamada M, Iwanaga Y,
Kitahama Y, Khang NV, Hirai S, Ohigashi I, Nitta S,
Amagai T et al. (2009) Gene expression profile of the
third pharyngeal pouch reveals role of mesenchymal
MafB in embryonic thymus development. Blood 113,
2976–2987.
7 Suzuki K, Numata T, Suzuki H, Raga DD, Ipulan LA,
Yokoyama C, Matsushita S, Hamada M, Nakagata N,
Nishinakamura R et al. (2014) Sexually dimorphic
expression of Mafb regulates masculinization of the
embryonic urethral formation. Proc Natl Acad Sci USA
111, 16407–16412.
8 Sarrazin S, Mossadegh-Keller N, Fukao T and Aziz A
(2009) MafB restricts M-CSF-dependent myeloid
commitment divisions of hematopoietic stem cells. Cell
138, 300–313.
9 Hamada M, Nakamura M, Tran MTN, Moriguchi T,
Hong C, Ohsumi T, Dinh TTH, Kusakabe M, Hattori
M, Katsumata T et al. (2014) MafB promotes
atherosclerosis by inhibiting foam-cell apoptosis. Nat
Commun 5, 3147.
10 Miyazaki T, Hirokami Y, Matsuhashi N, Takatsuka H
and Naito M (1999) Increased susceptibility of
thymocytes to apoptosis in mice lacking AIM, a novel
murine macrophage-derived soluble factor belonging to
the scavenger receptor cysteine-rich domain
superfamily. J Exp Med 189, 413–422.
11 Arai S, Shelton JM, Chen M, Bradley MN, Castrillo A,
Bookout AL, Mak PA, Edwards PA, Mangelsdorf DJ,
Tontonoz P et al. (2005) A role for the apoptosis
inhibitory factor AIM/Spalpha/Api6 in atherosclerosis
development. Cell Metab 1, 201–213.
12 Valledor AF, Hsu LC, Ogawa S, Sawka-Verhelle D,
Karin M and Glass CK (2004) Activation of liver X
receptors and retinoid X receptors prevents bacterial-
induced macrophage apoptosis. Proc Natl Acad Sci
USA 101, 17813–17818.
13 Martinez VG, Escoda-Ferran C, Sim~oes IT, Arai S,
Mascaro MO, Carreras E, Martınez-Florensa M,
Yelamos J, Miyazaki T and Lozano F (2014) The
macrophage soluble receptor AIM/Api6/CD5L displays
546 FEBS Open Bio 6 (2016) 540–547 ª 2016 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
MafB deficiency accelerates the development of obesity M. T. N. Tran et al.
a broad pathogen recognition spectrum and is involved
in early response to microbial aggression. Cell Mol
Immunol 11, 343–354.
14 Arai S and Miyazaki T (2014) Impacts of the apoptosis
inhibitor of macrophage (AIM) on obesity-associated
inflammatory diseases. Semin Immunopathol 36, 3–12.
15 Iwamura Y, Mori M, Nakashima K, Mikami T,
Murayama K, Arai S and Miyazaki T (2012) Apoptosis
inhibitor of macrophage (AIM) diminishes lipid
droplet-coating proteins leading to lipolysis in
adipocytes. Biochem Biophys Res Commun 422, 476–
481.
16 Kurokawa J, Arai S, Nakashima K, Nagano H,
Nishijima A, Miyata K, Ose R, Mori M, Kubota N,
Kadowaki T et al. (2010) Macrophage-derived AIM is
endocytosed into adipocytes and decreases lipid
droplets via inhibition of fatty acid synthase activity.
Cell Metab 11, 479–492.
17 Schlaeger TM, Mikkola HKA, Gekas C, Helgadottir
HB and Orkin SH (2005) Tie2Cre-mediated gene
ablation defines the stem-cell leukemia gene (SCL/tal1)-
dependent window during hematopoietic stem-cell
development. Blood 105, 3871–3874.
18 Kisanuki YY, Hammer RE, Miyazaki J-I, Williams SC,
Richardson JA and Yanagisawa M (2001) Tie2-Cre
transgenic mice: a new model for endothelial cell-
lineage analysis in vivo. Dev Biol 230, 230–242.
19 Hsu HC, Ema H, Osawa M and Nakamura Y (2000)
Hematopoietic stem cells express Tie-2 receptor in the
murine fetal liver. Blood 96, 3757–3762.
20 Oh DY, Morinaga H, Talukdar S, Bae EJ and Olefsky
JM (2012) Increased macrophage migration into
adipose tissue in obese mice. Diabetes 61, 346–354.
21 Lumeng CN, DeYoung SM, Bodzin JL and Saltiel AR
(2007) Increased inflammatory properties of adipose
tissue macrophages recruited during diet-induced
obesity. Diabetes 56, 16–23.
22 Amano SU, Cohen JL, Vangala P, Tencerova M,
Nicoloro SM, Yawe JC, Shen Y, Czech MP and
Aouadi M (2014) Local proliferation of macrophages
contributes to obesity-associated adipose tissue
inflammation. Cell Metab 19, 162–171.
23 Martinez-Santiba~nez G, Cho KW and Lumeng CN
(2014) Imaging white adipose tissue with confocal
microscopy. Methods Enzymol 537, 17–30.
24 Teresa Ortega M, Xie L, Mora S and Chapes SK
(2011) Evaluation of macrophage plasticity in brown
and white adipose tissue. Cell Immunol 271, 124–133.
25 Kurokawa J, Nagano H, Ohara O, Kubota N,
Kadowaki T, Arai S and Miyazaki T (2011) Apoptosis
inhibitor of macrophage (AIM) is required for obesity-
associated recruitment of inflammatory macrophages
into adipose tissue. Proc Natl Acad Sci USA 108,
12072–12077.
26 Arai S, Maehara N, Iwamura Y, Honda S-I,
Nakashima K, Kai T, Ogishi M, Morita K, Kurokawa
J, Mori M et al. (2013) Obesity-associated
autoantibody production requires AIM to retain the
immunoglobulin M immune complex on follicular
dendritic cells. Cell Rep 3, 1187–1198.
27 Maehara N, Arai S, Mori M, Iwamura Y, Kurokawa J,
Kai T, Kusunoki S, Taniguchi K, Ikeda K, Ohara O
et al. (2014) Circulating AIM prevents hepatocellular
carcinoma through complement activation. Cell Rep 9,
61–74.
28 Pettersson AML, Acosta JR, Bj€ork C, Kr€atzel J,
Stenson B, Blomqvist L, Viguerie N, Langin D, Arner
P and Laurencikiene J (2015) MAFB as a novel
regulator of human adipose tissue inflammation.
Diabetologia 58, 2115–2123.
29 Zhang Y, Chen Q and Ross AC (2012) Retinoic acid and
tumor necrosis factor-a induced monocytic cell gene
expression is regulated in part by induction of
transcription factor MafB. Exp Cell Res 318, 2407–2416.
547FEBS Open Bio 6 (2016) 540–547 ª 2016 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
M. T. N. Tran et al. MafB deficiency accelerates the development of obesity
